Transcranial direct current stimulation (a-tCDS) after subacromial injections in patients with subacromial pain syndrome: A randomized controlled pilot study
BMC Musculoskeletal Disorders Mar 19, 2021
Larrivée S, Balg F, Léonard G, et al. - Researchers conducted this pilot study with the aim to determine if the symptomatic relief provided by corticosteroid injections (CSI) in patients affected by subacromial pain syndrome (SAPS) could be enhanced by applying anodal transcranial direct current stimulation (a-tDCS). They randomly assigned 38 participants (18 to 65-year-old) suffering from SAPS to have a CSI as well as to receive, 1 weeks post CSI, real a-tDCS (r-tDCS), sham tDCS (s-tDCS) or no intervention (Control). Significant improvement in pain visual analog scales and Single Assessment Numeric Evaluation scale scores occurred in all groups following the CSI. Findings revealed no additive or potentializing effects of one session of a-tDCS treatment 2 weeks following CSI when compared with a s-tDCS or a control group.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries